Asbestos Diseases - Mesothelioma Treatments     |     Tuesday, February 09, 2010  
Home Page: Mesothelioma Facts & Information Newsletter

NEWSLETTER HOME

KAZAN LAW HOME


TOLL-FREE:
1-877-995-6372

CONTACT US


ADDRESS:
171 Twelfth Street
Third Floor
Oakland, California
94607
PH: 510-302-1000
Fax: 510-835-4913

Designed by Inherent



 Printer Friendly Page

Mesothelioma Treatment Options - Drug Therapy

Traditional Chemotherapy:

This traditional approach uses special anti-cancer (cytotoxic) medicines and chemicals to try to kill the malignant cells. Often, it is offered as an additional therapy alongside radical surgery and/or in combination with radiation therapy or immunotherapy, particularly when the cancer has spread beyond an operable area. Many drugs have been tried; however all have met with only limited success against malignant mesothelioma.

The chemotherapeutic agents can be administered either systemically (in the blood stream) or intrapleurally (in the pleural cavity itself.) These cytotoxic drugs are very potent and can have many severe side effects which you should discuss with your doctor.

Further Resources:

Understanding Chemotherapy - detailed information on chemotherapy, its side effects and current research: http://www.cancerbacup.org.uk/Cancertype/
Mesothelioma/Treatment/Chemotherapy

University of Pennsylvania Cancer Center's information page on chemotherapy: http://www.oncolink.org/types/article.cfm?c=3&s=5&ss=603&id=6998

Search the National Cancer Institute web site for current chemotherapy trials.

Malignant mesothelioma of the peritoneum is both rare and difficult to treat. Peritoneal perfusion chemotherapy has recently been used in patients with secondary peritoneal carcinomatosis with promising results. See E. De Bree, et al. - Malignant peritoneal mesothelioma treated by continuous hyperthermic peritoneal perfusion chemotherapy", in Annals of Oncology, 11:753-756.

A study comparing standard combination chemotherapy with infusional carboplatin. See White, S.C., et al. - "Randomized phase II study of cisplatin-etoposide versus infusional carboplatin in advanced non-small-cell lung cancer and mesothelioma" in Annals of Oncology, February 2000; 11(2):201-206.





In This Section:

Further Resources
Specific Mesothelioma Drug / Chemotherapy Treatments:

 
  KazanLaw:  Helping Asbestos Victims Since 1974

Home | Firm Profile | Attorneys | Practice Areas | Verdicts & News | Asbestos FAQs | Careers | Contact

Disclaimer

S. Kazan, Esq. © 1998 - 2010 Kazan, McClain, Abrams, Fernandez, Lyons, Farrise & Greenwood
A Professional Law Corporation. All Rights Reserved.